Literature DB >> 7510665

In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi.

P Sutton1, N R Newcombe, P Waring, A Müllbacher.   

Abstract

Aspergillosis is a disease caused by the opportunistic pathogen Aspergillus fumigatus and other related fungi. It occurs mainly in immunosuppressed people and causes very high mortality rates. A fumigatus and other pathogenic fungi have been shown to produce a metabolite, gliotoxin, which has immunosuppressive properties in vitro, but little is known about its in vivo activity. Here we report that gliotoxin has increased toxicity in mice after irradiation. A single injection of gliotoxin delayed the recovery of immune cells after immunosuppression by sublethal irradiation by 2 weeks. Study of the morphology of cells of the thymus, spleen, and mesenteric lymph nodes by light microscopy and electron microscopy and agarose gel electrophoresis of DNA from these organs showed that the injection of gliotoxin induced apoptosis in cells of the immune system in vivo. Thus, gliotoxin does have immunosuppressive activity in vivo and could potentially play a significant role in the pathogenesis of aspergillosis and other fungal diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510665      PMCID: PMC186256          DOI: 10.1128/iai.62.4.1192-1198.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

Review 1.  Apoptosis and programmed cell death in immunity.

Authors:  J J Cohen; R C Duke; V A Fadok; K S Sellins
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin.

Authors:  A Müllbacher; D Hume; A W Braithwaite; P Waring; R D Eichner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

3.  Clinical isolates of yeast produce a gliotoxin-like substance.

Authors:  D T Shah; B Larsen
Journal:  Mycopathologia       Date:  1991-12       Impact factor: 2.574

4.  Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity.

Authors:  A Müllbacher; P Waring; U Tiwari-Palni; R D Eichner
Journal:  Mol Immunol       Date:  1986-02       Impact factor: 4.407

5.  Prevention of graft-versus-host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire.

Authors:  A Müllbacher; A F Moreland; P Waring; A Sjaarda; R D Eichner
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

6.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

7.  Fungal infections in liver transplant recipients.

Authors:  C P Wajszczuk; J S Dummer; M Ho; D H Van Thiel; T E Starzl; S Iwatsuki; B Shaw
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

8.  Fungal infections in cancer patients: an international autopsy survey.

Authors:  G Bodey; B Bueltmann; W Duguid; D Gibbs; H Hanak; M Hotchi; G Mall; P Martino; F Meunier; S Milliken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

9.  Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation.

Authors:  S Kusne; J Torre-Cisneros; R Mañez; W Irish; M Martin; J Fung; R L Simmons; T E Starzl
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

10.  Immunosuppression in vitro by a metabolite of a human pathogenic fungus.

Authors:  A Müllbacher; R D Eichner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  44 in total

1.  Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus.

Authors:  Jose L Blanco; Raquel Hontecillas; Emilio Bouza; Isabel Blanco; Teresa Pelaez; Patricia Muñoz; Jose Perez Molina; Marta E Garcia
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Programmed cell death in thymus during experimental paracoccidioidomycosis.

Authors:  Paula C S Souto; Vânia N Brito; Jacy Gameiro; Maria Alice da Cruz-Höfling; Liana Verinaud
Journal:  Med Microbiol Immunol       Date:  2003-04-08       Impact factor: 3.402

3.  Septic mice are susceptible to pulmonary aspergillosis.

Authors:  Claudia F Benjamim; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.

Authors:  Robert A Cramer; Michael P Gamcsik; Rhea M Brooking; Laura K Najvar; William R Kirkpatrick; Thomas F Patterson; Carl J Balibar; John R Graybill; John R Perfect; Soman N Abraham; William J Steinbach
Journal:  Eukaryot Cell       Date:  2006-06

5.  Culture filtrates of Aspergillus fumigatus induce different modes of cell death in human cancer cell lines.

Authors:  P Daly; S Verhaegen; M Clynes; K Kavanagh
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

6.  A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.

Authors:  Zaida G Ramirez-Ortiz; Chrono K Lee; Jennifer P Wang; Louis Boon; Charles A Specht; Stuart M Levitz
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

7.  Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.

Authors:  Emer P Reeves; C G M Messina; S Doyle; K Kavanagh
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

8.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  The crucial role of the Aspergillus fumigatus siderophore system in interaction with alveolar macrophages.

Authors:  Markus Schrettl; Oumaima Ibrahim-Granet; Sabrina Droin; Michel Huerre; Jean-Paul Latgé; Hubertus Haas
Journal:  Microbes Infect       Date:  2010-07-24       Impact factor: 2.700

10.  Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes.

Authors:  Yuya Sato; Yayoi Tsuboi; Hidemitsu Kurosawa; Kenichi Sugita; Mitsuoki Eguchi
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.